These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17119453)

  • 21. Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma.
    Doukas J; Rolland A
    Cancer Gene Ther; 2012 Dec; 19(12):811-7. PubMed ID: 23037806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phase I-II trial of gene therapy with tag-7 modified autologous tumor cells in patients with metastatic solid tumors].
    Moiseenko VM; Danilov AO; Baldueva IA; Danilova AB; Tiukavina NV; Larin SS; Kiselev SL; Orlova RV; Semenova AI; Turkevich EA; Shchelkina LA; Anisimov VV; Gafton GI; Kochnev VA; Barchuk AS; Kanaev SV; Khanson KP; Georgiev GP
    Vopr Onkol; 2004; 50(3):293-303. PubMed ID: 15318702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
    Eisen T; Thomas J; Miller WH; Gore M; Wolter P; Kavan P; Martín JA; Lardelli P
    Melanoma Res; 2009 Jun; 19(3):185-92. PubMed ID: 19436178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
    Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
    Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.
    Olivier KR; Schild SE; Morris CG; Brown PD; Markovic SN
    Cancer; 2007 Oct; 110(8):1791-5. PubMed ID: 17721993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.
    Tarhini AA; Millward M; Mainwaring P; Kefford R; Logan T; Pavlick A; Kathman SJ; Laubscher KH; Dar MM; Kirkwood JM
    Cancer; 2009 Feb; 115(4):859-68. PubMed ID: 19140204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
    Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
    Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
    Thompson JA; Curti BD; Redman BG; Bhatia S; Weber JS; Agarwala SS; Sievers EL; Hughes SD; DeVries TA; Hausman DF
    J Clin Oncol; 2008 Apr; 26(12):2034-9. PubMed ID: 18347008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.
    Davis ID; Skrumsager BK; Cebon J; Nicholaou T; Barlow JW; Moller NP; Skak K; Lundsgaard D; Frederiksen KS; Thygesen P; McArthur GA
    Clin Cancer Res; 2007 Jun; 13(12):3630-6. PubMed ID: 17575227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
    Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
    Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional therapy for advanced melanoma: promise and limitation.
    Agarwala SS
    Curr Opin Oncol; 2015 Mar; 27(2):151-6. PubMed ID: 25629369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoablation of metastatic melanoma using intralesional Rose Bengal.
    Thompson JF; Hersey P; Wachter E
    Melanoma Res; 2008 Dec; 18(6):405-11. PubMed ID: 18830132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
    Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
    Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.
    Mann BS; Johnson JR; Cohen MH; Justice R; Pazdur R
    Oncologist; 2007 Oct; 12(10):1247-52. PubMed ID: 17962618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developments in Intralesional Therapy for Metastatic Melanoma.
    Sloot S; Rashid OM; Sarnaik AA; Zager JS
    Cancer Control; 2016 Jan; 23(1):12-20. PubMed ID: 27009452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
    Dudek AZ; Mescher MF; Okazaki I; Math VT; Luo X; Curtsinger JM; Miller JS
    Am J Clin Oncol; 2008 Apr; 31(2):173-81. PubMed ID: 18391603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma.
    Schachter J; Katz U; Mahrer A; Barak D; David LZ; Nusbacher J; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Sep; 1110():305-14. PubMed ID: 17911445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional immunotherapy as a strategy to treat melanoma.
    Nouri N; Garbe C
    Expert Opin Biol Ther; 2016; 16(5):619-26. PubMed ID: 26898656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.